Global Conference 2010
Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson
Garry Neil is Corporate Vice President of the Corporate Office of Science and Technology at Johnson & Johnson. Neil's team identifies and launches emerging technologies that underpin the creation of future businesses. He has held a number of senior positions at Johnson & Johnson, including group president of pharmaceutical research and development. Under his leadership, approvals have been granted for a number of important new medicines for the treatment of cancer, anemia, infections, central nervous system and psychiatric disorders, pain, and genitourinary and gastrointestinal diseases. Previously, Neil held senior-level positions with Astra Merck Inc., Astra Pharmaceuticals, AstraZeneca and Merck KGaA. He has also held academic posts at the Ludwig Institute for Cancer Research, the University of Toronto, the University of Iowa College of Medicine and the University of Pennsylvania (adjunct). He received a medical degree from the University of Saskatchewan College of Medicine.